Open | - |
Close | - |
Volume / Avg. | 1.611K / 1.590M |
Day Range | - - - |
52 Wk Range | 0.226 - 1.750 |
Market Cap | $18.636M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 0.05% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NuCana (NASDAQ: NCNA) through any online brokerage.
Other companies in NuCana’s space includes: Galecto (NASDAQ:GLTO), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO), Indaptus Therapeutics (NASDAQ:INDP) and Tonix Pharmaceuticals (NASDAQ:TNXP).
The latest price target for NuCana (NASDAQ: NCNA) was reported by Oppenheimer on Tuesday, November 21, 2023. The analyst firm set a price target for 4.00 expecting NCNA to rise to within 12 months (a possible 1033.14% upside). 4 analyst firms have reported ratings in the last year.
The stock price for NuCana (NASDAQ: NCNA) is $0.353 last updated Today at March 19, 2024 at 4:03 AM EDT.
There are no upcoming dividends for NuCana.
NuCana’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for NuCana.
NuCana is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.